Ascendis Pharma
ASND
#1548
Rank
โ‚น1.310 T
Marketcap
โ‚น21,353
Share price
0.02%
Change (1 day)
63.36%
Change (1 year)

Revenue for Ascendis Pharma (ASND)

Revenue in 2024: โ‚น33.24 Billion

According to Ascendis Pharma 's latest financial reports the company's current revenue (TTM ) is โ‚น66.07 Billion. In 2024 the company made a revenue of โ‚น33.24 Billion an increase over the revenue in the year 2023 that were of โ‚น24.24 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ascendis Pharma from 2014 to 2024

Annual revenue

Year Revenue Change
2024โ‚น33.24 B37.09%
2023โ‚น24.24 B447.4%
2022โ‚น4.42 B567.18%
2021โ‚น0.66 B14.09%
2020โ‚น0.58 B-45.52%
2019โ‚น1.06 B26.17%
2018โ‚น0.84 B657.64%
2017โ‚น0.11 B-67.76%
2016โ‚น0.34 B-41.56%
2015โ‚น0.59 B-49.14%
2014โ‚น1.16 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Akebia Therapeutics
AKBA
โ‚น20.45 B-69.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
โ‚น87.39 M-99.87%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
โ‚น10.35 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA